Adlai Nortye

ANLNasdaq Cayman Islands Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$967.574 M

$13.28 -4.05%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#162ArdelyxARDX$988.1M
#163Avalo TherapeuticsAVTX$969.2M
#164Adlai NortyeANL$967.6M
#165Janux TherapeuticsJANX$966.6M
#166OmerosOMER$959.0M

Where these numbers come from

Share counts and financials for Adlai Nortye are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.